Insights & Perspectives

Filter by

Therapeutic Area / Research

Search Insights:
Showing 1 to 10 of 27
Filter by: Case Study

Case Study | Feb 15, 2019

Beyond the Guidelines: Uncovering Subtle Differences in Patient Management for a Rare Disease

It’s all in the detail, and that’s especially true for leveraging real life data to better understand the subtle differences in patient management for a rare disease, as well as characterizing the therapeutic response to current therapies.

Read more | | Share

Case Study | Feb 15, 2019

Optimizing Your Clinical Development Plan for Rare Disease

New study effectively captures the patient pathway when patients exit the healthcare system due to lack of therapy

Read more | | Share

Case Study | Nov 11, 2018

Classic Market Research Coupled with Unique Framework Yields Valuable Patient Insights for New Oncology Therapies

Kantar Health recently conducted a breakthrough study about the nutritional journeys of Chinese oncology patients that offers valuable information for the development of advanced therapies.

Read more | | Share

Case Study | Oct 21, 2018

Study Finds That A Simple Adherence Measure Improves Outcomes

A leading pharmaceutical company wanted to understand whether medication non-adherence is associated with glycated hemoglobin (HbA1c) and other non-clinical health outcomes among type 2 diabetes patients using basal insulin analogs.

Read more | | Share

Case Study | Sep 25, 2018

Leveraging the Power of South Korea’s HIRA Database

Kantar Health has the know-how when it comes to using and optimizing the HIRA database, as we’ve built up our experience by communicating with HIRA officials and analyzing HIRA data in South Korea.

Read more | | Share

Case Study | Aug 14, 2018

Identifying Intervention Opportunities Across the Patient Journey

One of the world’s leading pharmaceutical companies wanted to better understand intervention opportunities across the patient journey for immunology diseases and from the patient's perspective.

Read more | | Share

Case Study | Jul 15, 2018

Launching a Pediatric Rare Disease Drug in China

Kantar Health recently implemented a mixed-methods research approach to maximize uptake and patient benefit for a critical metabolic disease medicine across 11 Chinese provinces.

Read more | | Share

Case Study | Jul 6, 2018

Patient-Centric HERO Framework Provides Key Insights to Brand Success

In this case study, we detail how a leading global pharmaceutical company wanted to determine the relation of efficacy, therapy acceptance and therapy satisfaction in influencing medication adherence for its intermittent long-term treatment for atopic dermatitis.

Read more | | Share

Case Study | Apr 4, 2018

Realizing the Rewards of Multi-channel Marketing and Touchpoint Optimization

Learn how Kantar Health employed touchpoint optimization methodologies to provide our client with actionable insights to guide their long-term brand building and brand growth strategies.

Read more | | Share

Case Study | Oct 12, 2017

Successful Brand Optimization Strategies Require Deep Market Understanding

A top 10 oncology therapy company wanted to better understand market opportunities for a new indication within its oncology franchise. This case study outlines our first-of-its-kind solution for helping the client comprehensively prepare for pilot and track performance on the launch of the new indication.

Read more | | Share
Page  < 123 >